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The presence of the giant virus of amoeba Marseillevirus has been identified at many
different sites on the human body, including in the bloodstream of asymptomatic
subjects, in the lymph nodes of a child with adenitis, in one adult with Hodgkin’s
disease, and in the pharynx of an adult. A high seroprevalence of the Marseillevirus
has been recorded in the general population. Whether Marseillevirus can disseminate
and persist within a mammal after entry remains unproven. We aimed to assess the
ability of the virus to disseminate and persist into healthy organisms, especially in the
lymphoid organs. Parenteral inoculations were performed by intraperitoneal injection
(in rats and mice) or intravenous injection (in rats). Airway inoculation was performed
by aerosolization (in mice). Dissemination and persistence were assessed by using
PCR and amebal co-culture. Serologies were performed by immunofluorescent assay.
Pathological examination was conducted after standard and immunohistochemistry
staining. After intraperitoneal inoculation in mice and rats, Marseillevirus was detected
in the bloodstream during the first 24 h. Persistence was noted until the end of the
experiment, i.e., at 14 days in rats. After intravenous inoculation in rats, the virus was first
detected in the blood until 48 h and then in deep organs with infectious virus detected
until 14 and 21 days in the liver and the spleen, respectively. Its DNA was detected
for up to 30 days in the liver and the spleen. After aerosolization in mice, infectious
Marseillevirus was present in the lungs and nasal associated lymphoid tissue until 30
days post inoculation but less frequently and at a lower viral load in the lung than in the
nasal associated lymphoid tissue. No other site of dissemination was found after aerosol
exposure. Despite no evidence of disease being observed, the 30-day long persistence
of Marseillevirus in rats and mice, regardless of the route of inoculation, supports the
hypothesis of an infective potential of the virus in certain conditions. Its constant and
long-term detection in nasal associated lymphoid tissue in mice after an aerosol exposure
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suggests the involvement of naso-pharyngeal associated lymphoid tissues in protecting
the host against environmental Marseillevirus.
Keywords: marseillevirus, experimental infection, murinemodel, giant viruses,Megavirales, NCLDV, pathogenicity
INTRODUCTION
Giant viruses of amoebas were discovered in 2003, with
the isolation of Acanthamoeba polyphaga Mimivirus by co-
culturing on amoeba. Marseilleviridae is a new family of
amoebal giant viruses defined in 2012 (Colson et al., 2013b).
Its founding member is Marseillevirus (Boyer et al., 2009),
and in addition 12 other members have been described to
date including Senegalvirus, Cannes 8 virus, Fontaine Saint
Charles virus, Melbournevirus, Lausannevirus, Tokyovirus,
Tunsivirus, Insectomime virus, Brazilian Marseillevirus, Golden
Marseillevirus, and Port-Miou virus (Boyer et al., 2009; La
Scola et al., 2010; Thomas et al., 2011; Lagier et al., 2012;
Aherfi et al., 2013, 2014; Boughalmi et al., 2013; Doutre et al.,
2014, 2015; Dornas et al., 2016; Takemura, 2016). Subsequently,
contact between giant viruses and humans were suggested.
Concordant data argue for the pathogenicity of these viruses,
such as mimiviruses-associated pneumonia (La Scola et al., 2005;
Raoult et al., 2006; Bousbia et al., 2013; Saadi et al., 2013a,b)
or the recently described association between phycodnaviruses
and cognitive impairment (Yolken et al., 2014). The presence
of giant viruses of amoeba, including those of marseilleviruses
within human biological material, was more recently revealed
by high throughput metagenomics, confirming contacts between
these viruses and humans (Colson et al., 2013a; Rampelli et al.,
2016; Verneau et al., 2016).
Senegalvirus was the first marseillevirus to be isolated from
human samples, following its serendipitous detection during
a microbial metagenomic study conducted on the stools of
a healthy Senegalese man (Lagier et al., 2012). In 2013, a
metagenomic study further revealed the presence of a substantial
number of reads matching the Marseillevirus genome in the viral
fraction of healthy blood donors (Popgeorgiev et al., 2013a).
Hypotheses were then generated around blood carriage and
the blood-borne transmission of Marseillevirus. Furthermore,
two seroprevalence studies unexpectedly suggested frequent
contacts between humans and Marseillevirus (Mueller et al.,
2013; Popgeorgiev et al., 2013b). The detection of giant
viruses of amoebae in humans in association with clinical
symptoms may be coincidental, but this is nevertheless an
emerging issue. A single clinical observation has reported
the detection of a marseillevirus in a pathological lymph
node of a 11-month-old boy with lymphadenitis (Popgeorgiev
et al., 2013c). We subsequently reported the presence of
Marseillevirus in the blood and lymph nodes of a patient
with Hodgkin’s disease (Aherfi et al., 2016a). We also detected
Marseillevirus DNA by PCR in two pharyngeal samples
collected from a 20-year-old patient presenting neurological
disorders at a one-year interval, strongly suggesting the viral
persistence of this agent in the tonsils (Aherfi et al., 2016b).
To date, no data argued for Marseillevirus propagation in
mammal cells and no causal relationship has been established
between the presence of this virus and clinical symptoms
or diseases observed in these different cases. The only one
known host of Marseillevirus that allows a complete lytic
cycle is Acanthamoeba cells. To our knowledge, the study of
viruses in non host organisms and their interaction remain
an unexplored area of virology. Taken together, these findings
suggest however that the particles or DNA markers of
Marseillevirus may persist during a long period in humans in
some cases. Such a hypothesis requires further experimental
data.
With this goal, we set up a murine model using rats and mice
and different routes of inoculation to assess the dissemination
and the persistence of Marseillevirus in mammalian organisms.
The aerosol route, we think plausible route of transmission of
this waterborne virus (Boyer et al., 2009), was tested first with
a special focus on the localization and persistence of the virus
in the nasal associated lymphoid tissue (NALT) as an equivalent
to the human tonsils. We also tested the intraperitoneal and the
intravenous routes in mice and rats.
MATERIALS AND METHODS
Ethics Statements and General Procedures
in Vivo
For animal studies, the experimental protocols, registered
by the “Ministère de l’Enseignement Supérieur et de la
Recherche” under reference number 20150528122362 and
2015060517005844, were approved by the Institutional Animal
Care and Use Committee of Aix-Marseille University “C2EA-14,”
France. We used Balb/c mice between 4 and 8 weeks old (Envigo
Laboratories, Gannat, France) weighing between 16 and 25 g,
and Swiss rats weighing between 330 and 770 g. Animals were
housed in individual plastic cages (five mice or two rats per cage)
in a ventilated pressurized cabinet (A-BOX 160, Noroit, Rezé,
France) with free access to water and standard diet food until the
experiment. All animals were housed in protected environmental
area and received standard diet including dehydrated rodent feed
pellets and sterile water.
Airway inoculation was performed by aerosol delivery using
the whole-body inhalation exposure systemA4224 (IES, Glas-Col
LLC, Terre Haute, USA). Intraperitoneal (IP) and intravenous
(IV) inoculations were performed under volatile anesthesia with
5% isoflurane, by percutaneous puncture of the abdomen or
injection into the tail vain, respectively.
Control animals received phosphate buffered saline (PBS) via
the aerosolized, IP or IV routes according to the same time
of exposure or the same volume as infected animals. After
inoculations, the animals were transferred into cages and housed
in a safety cabinet with food and water ad libitum.
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Serial blood samples were taken from the IV injected
rats over time by tail vein puncture to describe the kinetics
of viremia. At the end of the experiments, the rats were
euthanized with a lethal dose of thiopental (Panpharma, France)
administered intraperitoneally and the mice were euthanized
with exsanguination performed under volatile anesthesia.
Additional blood and organ samples were collected post-mortem.
Strains, Culture Conditions, and
Preparation of Infective Inoculums for
Animal Experiments
Marseillevirus strain T19 was co-cultured on axenic
Acanthamoeba castellanii, in peptone yeast extract broth
with glucose medium (PYG). The culture supernatants were then
concentrated and purified as previously described and finally
washed in PBS (Dornas et al., 2015). The purified virus was
aliquoted and stored at −80◦C for further use. Ten days before
the animals were inoculated, the viable virus was quantified
by end point dilution by co-culturing on A. castellanii. At this
end, serial dilutions of the virus suspension with a dilution
factor of 10 were inoculated to amoebas at a concentration of
5.105/mL deposited in a 24 well plate. Amoebas were inoculated
with each dilution of virus in quadruplicate. The amoeba were
checked for lysis 7 days after inoculation. The concentration of
the viable virus was those that allowed the amoeba lysis in two
wells of the four that were inoculated with this concentration.
The concentration of purified viable virus ranged between
7 and 7.5 log units per µL. Purified viruses were diluted in
PBS immediately before inoculating the animals, to reach the
appropriate inoculums (see “Animal experiments”).
Inoculation of Marseillevirus in Vivo
For airway inoculation, 81 mice (34 males, 47 females) were
aerosol-inoculated with a suspension of PBS containing nine
log units of viruses per mL placed into the glass vial for
liquid venturi aerosol generation following the manufacturer’s
recommendations and custom settings. As assessed on animals
euthanized just after aerosol exposition (n = 4), the initial viral
lung inoculum ranged between 4.9 and 5.7 (mean 5.6) log units
of viral copies per million murine cells.
For the parenteral inoculations, eight log units of viable virus
diluted in 300 µL of PBS were injected to 21 rats IV and 12 rats
IP. For mice, seven log units of viable virus diluted in 200 µL of
PBS were injected IP (n= 15).
Follow-Up and Samplings
After the inoculations, the animals were observed daily for signs
of discomfort or illness.
The IP route was assessed for 24 h in mice and until 2 weeks
post-inoculation (PI) in a series of rats euthanized at 12 h, and at
days 1, 3, 7, 14, and 43 PI. The IV route in rats was assessed until
day 43 PI, with evaluation taking place at 12 h, and on days 1, 2
(blood only), 3, 7, 14, 21, 30, and 43 PI. The aerosol route in mice
was assessed until 1 month PI with evaluation taking place at 2 h,
and on days 1, 7, 14, 21, and 30 PI.
For all animals, the spleen, liver, and blood were collected.
In addition, the omentum and mesenteric lymph nodes from
IP inoculated rats, the cervical lymph nodes from IV inoculated
rats, the lungs, the NALT, and the cervical and tracheal lymph
nodes from aerosol inoculated mice were sampled immediately
post mortem. Spleen weight was immediately recorded and blood
was aliquoted for PCR and serology.
To avoid detecting the possible contamination of the external
organ with the virus due to the IP inoculation process, the
removed abdominal organs were decontaminated in two baths
of 70◦ ethanol and then washed in PBS before culture and PCR
processing.
Each freshly sampled organ was separately crushed in PBS for
amoebal co-culture and DNA extraction was performed for PCR.
Representative samples of lungs, lymph nodes, NALT, spleen
and liver from each evaluation time were fixed in 4% formalin
for histological analyses, including a total of 10 spleen and liver
samples, 11 lung samples, and 12 NALT samples from aerosol
inoculated mice.
Amoebal Co-culture
A. castellanii was cultured at 28◦C in PYG. When amoebas
were confluent, they were centrifuged, and the pellet was
resuspended in sterile Page’s amoeba saline solution twice.
Finally, amoebas were resuspended in survival buffer solution
at a final concentration of between 5.105 and 1.106 cells/mL
with an antimicrobial mix consisting of imipenem / cilastatin
(10µg/mL), vancomycin (10µg/mL), ciprofloxacin (20µg/mL),
doxycycline (20µg/mL), and voriconazole (20µg/mL). Amoebas
were distributed in 24-well plates (500 µL of amoeba culture
per well). 50 µL of each of the crushed organs was then
deposited on the cell layer and incubated at 30◦C for 3
days. Two sub-cultures were performed. When amoeba lysis
occurred, 100 µL of the well content was spotted on a slide
and colored using hemacolor staining (Hemacolor R©, Merck,
Darmstadt, Germany) to check for the presence of viral
factories (Boughalmi et al., 2012; Figure 1). Wells containing
only amoebas were included in each microplate as negative
controls.
Molecular Detection of Marseillevirus
The DNA from the total blood and from the crushed organs was
extracted using a QIAamp Tissue Kit (Qiagen). Two systems
of specific primers and probes were used for quantitative
real-time PCR (reg4-2-F: CCCAACAGAGGCCGAAATT,
reg 4-2R: CCTTCTGTACGAGGCCAAAA, probe reg4-2:
TCCTCCCCAGAACCAGACTCTCCA, reg 8-2 F: TCT
TGTCTGGCTTTCCCTTC, reg8-2 R: GTGTCTCTG
CCTGTCCAAA, probe reg8-2: AGTGAGGAGTCTG
TTGGCCGCA). These two systems target specifically
MAR_ORF210 (encoding a hypothetical protein excluded
from Genbank database due to the lack of start codon) and
MAR_ORF055 (encoding a RNA polymerase Rpb1 domains
1-2), respectively. These two genes are in single copies in the
Marseillevirus strain T19 genome. When an amplification was
obtained and a fluorescence signal was generated by testing both
the two systems of PCR, the result was considered as positive if
the cycle threshold was <35 for at least one of the two systems.
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FIGURE 1 | Representative photomicrographs of co-culture of mice and rats samples on Acanthamoeba castellanii. Pictures (a–d) show positive samples by
co-culture as indicated by the visible infected amoebas with Marseillevirus. These samples include NALT from aerosol inoculated mice and spleen from rats after IV
inoculation with Marseillevirus. The arrows indicate viral factories and N indicate the nucleus of amoeba. Pictures (e,f) show negative samples by amoebal co-culture:
the amoebas are not infected and do not contain viral factories.
When amplification was obtained and a fluorescent signal
was generated with only one of the two systems, whichever
the cycle threshold, the result was considered as negative.
The amplification of housekeeping genes hydroxymethylbilane
synthase and glyceraldehyde-3-phosphate dehydrogenase were
used as internal controls for mice and rats, respectively (Huang
et al., 2008; Ding et al., 2014).
Real time PCR assays were performed using the CFX96 R©
qPCR Detection System (Bio-Rad, France). Negative controls
consisted of DNA extracted from the organs and blood of
PBS-challenged mice and rats (two animals for each route
of inoculation). Positive controls were DNA extracted from
Marseillevirus culture supernatants.
Viral loads were calculated on the basis of the calibration
standard curve of DNA from a suspension of purified
Marseillevirus, the concentration of which was determined by
flow cytometry (Brussaard, 2004). To standardize the amounts,
the viral loads into the tissues were expressed as n log units of
viral copies per million murine cells.
Immunofluorescence Assay for
Marseillevirus Antibodies Detection in Sera
In the aim to have positive controls for serological tests on the
rats and mice of the experiments, we previously immunized
a rabbit with Marseillevirus by the subcutaneous route. After
three inoculations, serum from the rabbit consisting in polyclonal
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antibodies specific to Marseillevirus, was collected and used as a
positive control for serological testing.
Purified Marseillevirus was spotted on microscope slides. Sera
collected from rats and mice were tested at the 1:50 dilution in
PBS. Sera were deposited on the spots and incubated 30min at
37◦C. Slides were washed twice in PBS/Tween20 0.5% during
8min, once in distilled water during 8min, then dried. The
presence of antibodies was detected using a FITC (fluorescein
isothiocyanate) conjugated goat anti-mouse IgG (Immunotech,
Marseille, France), anti-mouse IgM at 1: 400 dilution (Jackson
Immunoresearch Laboratories, West Grove, USA) for mouse
sera, and anti-rat IgG (Jackson ImmunoResearch, Suffolk,
United Kingdom) for rat sera, with Evans blue counterstain
0.25%. Slides were incubated at 37◦C during 30min, washed
twice in PBS/Tween 20 0.5% during 8min, once in distilled water
during 8min, then dried. The slides were then observed after
adding 1 drop of Fluoprep (Biomérieux, France) and coverslips,
on a microscope Leica DM 2,500 (Leica, Wetzlar, Germany)
at 488 nm wavelength. As negative controls, sera from non-
immunized mice were included in each experiment. Positive
controls consisted in sera from immunized rabbit. The threshold
for positivity of serology was the 1:50 dilution of the mice and
rat sera. A result was considered as positive if the two observers,
blind to group assignment, so concluded. Any discordant result
was considered as negative.
RESULTS
Dissemination of the Virus
In IP inoculated rats and mice, dissemination of the virus into
the bloodstream was observed at day 1 PI, as attested by positive
PCR in two of the four rats and two of the four mice tested
(Supplementary Files 1, 2). The mean viral loads were at day 0,
3.9, and 6.1 and at day 1, 3.9, and 8 log units per million murine
cells, respectively in rats and mice. Blood samples induced
amoeba lysis in 5/7 of the rat and mice blood samples collected
at day 0 and 2/8 at day 1 PI. Dissemination of the viable virus to
deep organs was also observed in the spleen and liver (see below
“Persistence of viruses”).
As expected, after IV inoculation in rats, the virus was detected
in blood samples, but also in deep organs as attested by amoeba
co-culture and PCR (Tables 1, 2, Figure 2, Supplementary File 3).
At 24 h PI, the liver, spleen and lungs were found positive for all
the rats tested (4/4).
In aerosol inoculated mice, all animals had negative PCR
and co-culture for the blood, spleen, liver and lymph nodes. In
contrast, the lungs and NALT were frequently positive, regardless
of the sample time, i.e., in 111 of 133 (83%) of the whole tested
samples from aerosol inoculated mice, including 50 of 70 (71%)
lung samples and 61 of 63 (97%) NALT samples (Figure 3,
Supplementary File 4).
Persistence of Viruses
After IP inoculation, viable Marseillevirus i.e., detected by co-
culture was detected in the spleen from the 12 h PI and
persisted until the end of the experiment 14 days later (3/3 rats)
(Supplementary File 2). In the liver and the omentum, the viable
virus was recovered in the first seven days in rats, and viral DNA
i.e., detected by PCR persisting up to day 14 in both organs.
After IV inoculation in rats, the blood detection of
Marseillevirus persisted up to 48 h PI in eight of the eight tested
blood samples (PCR and culture). In the other organs, the viable
virus was detected until days 14 and 21 in the liver and the spleen,
respectively, while viral DNA persisted up to day 30 PI in both
organs (Figure 4, Supplementary File 3).
After aerosolization, viable Marseillevirus persisted at least 30
days in the NALT in all the mice tested, and in only one lung
sample of the four collected at the same time point (Figure 3,
Supplementary File 4). Immediately after aerosolization and after
12 h post exposure, the viral load did not significantly differ
between the NALT and the lung samples (p= 0.27). Between days
1 and 7 PI, the NALT viral loads increased. Moreover, from days 1
to 21 PI, the NALT viral loads were higher than in the lungs, then,
despite decreasing, remained above the lung viral load (Figure 5).
Serology
A total of 111 sera including nine from IP inoculated rats, 20
from IV inoculated rats and 82 from aerosol inoculatedmice were
tested.
After parenteral inoculation, of the eight sera collected
between days 1 to 7 PI, two collected on day 7 PI, were positive
for anti-Marseillevirus IgG. In IV inoculated rats, IgG anti-
Marseillevirus antibodies were found in one of four sera collected
on day 7 PI and 10 of 11 sera tested between days 14 and 43 PI. A
representative microphotograph is presented in Supplementary
File 5.
Only one aerosol inoculated mouse showed an IgG antibody
response to Marseillevirus (sampled at day 30 PI).
All sera were negative for IgM, regardless of the inoculation
route.
In eight cases, a positive signal was found by only one of the
two observers. These samples were recorded as being negative.
This concerned IgM antibodies on day 7 for two animals and day
16 for two others, and IgG at day 23 for four animals.
Clinical Outcome
No spontaneous deaths occurred and no animal presented signs
of discomfort throughout the course of the experiment, whatever
the route of virus inoculation. A regular gain in body weight
occurred in all infected and control animals.
Histopathological Findings
No histological lesions were found in anymurine tissue including
NALT, the lungs, spleen, liver, cervical and tracheal lymph nodes.
DISCUSSION
In this paper, we describe, for the first time to our knowledge, the
purposeful transmission of the giant Marseillevirus to a murine
host. By including different routes of inoculation, our model
aimed to assess the tropism, persistence and dissemination of
the virus. We report a 30-day long persistence of the virus in
immunocompetent rats and mice inoculated by the IP, IV and
respiratory routes. The virus was able to disseminate from the
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TABLE 1 | Summary of results obtained by qPCR of blood and organs of rats and mice inoculated with Marseillevirus.
PCR Day 0 Day 1 Day 2 Day 3 Day 7 Day 14 Day 21 Day 30 Day 43
IP route Rats Blood Positive
33.0
(n = 2/3)
Positive
33.3
(n = 1/4)
ND Negative
-
(n = 0/2)
Negative
-
(n = 0/4)
Negative
-
(n = 0/3)
ND ND NI
Spleen ND Positive
33.7
(n = 2/2)
ND Positive
34.9
(n = 1/2)
Positive
34.7
(n = 3/3)
Positive
33.6
(n = 3/3)
ND ND Negative
-
(n = 0/1)
Liver ND Positive
33.3
(n = 1/2)
ND Positive
34.9
(n = 1/2)
Negative
(n = 0/2)
Positive
33.7
(n = 2/3)
ND ND Negative
-
(n = 0/1)
Mice Blood Positive
31.8
(n = 2/4)
Positive
31.7
(n = 2/4)
Positive
32.0
(1/3)
ND Negative
-
(n = 0/3)
ND Negative
-
(n = 0/1)
ND ND
Spleen Positive
31.7
(n = 3/4)
Positive
33.2
(n = 2/4)
Positive
34.2
(n = 1/3)
ND Positive
31.0
(n = 1/3)
ND Negative
-
(n = 0/1)
ND ND
Liver ND ND ND ND ND ND ND ND ND
IV route Rats Blood ND Positive
33.2
(n = 4/4)
Positive
32.8
(n = 2/2)
Negative
-
(n = 0/2)
Negative
-
(n = 0/3)
Negative
-
(n = 0/3)
Negative
-
(n = 0/3)
Negative
-
(n = 0/3)
Negative
-
(n = 0/2)
Spleen ND Positive
29.4
(n = 4/4)
ND Positive
31.1
(n = 3/3)
Positive
29.0
(n = 2/3)
Positive
31.5
(n = 3/3)
Positive
28.2
(n = 2/2)
Positive
28.6
(n = 2/3)
Negative
-
(n = 0/2)
Liver ND Positive
29.2
(n = 4/4)
ND Positive
29.0
(n = 3/3)
Positive
31.0
(n = 1/3)
Positive
30.2
(n = 3/3)
Positive
28.2
(n = 2/2)
Positive
29.1
(n = 2/3)
Negative
-
(n = 0/2)
Aerosol
route
Mice Blood Negative
-
(n = 0/4)
Negative
-
(n = 0/15)
ND ND Negative
-
(n = 0/17)
Negative
-
(n = 0/15)
Negative
-
(n = 0/12)
Negative
-
(n = 0/5)
ND
Spleen Negative
-
(n = 0/4)
Negative
-
(n = 0/15)
ND ND Negative
-
(n = 0/18)
Negative
-
(n = 0/15)
Negative
-
(n = 0/14)
Negative
-
(n = 0/5)
ND
Liver Negative
-
(n = 0/4)
Negative
-
(n = 0/15)
ND ND Negative
-
(n = 0/18)
Negative
-
(n = 0/15)
Negative
-
(n = 0/14)
Negative
-
(n = 0/5)
ND
Lung Positive
26.1
(n = 4/4)
Positive
28.4
(n= 15/15)
ND ND Positive
30.7
(n= 16/18)
Positive
34.6
(n = 8/15)
Negative
-
(n = 0/14)
Negative
-
(n = 0/4)
ND
NALT Positive
29.7
(n = 2/2)
Positive
31.0
(n= 11/15)
ND ND Positive
31.5
(n= 18/18)
Positive
33.6
(n= 13/15)
Positive
34.8
(n = 7/14)
Positive
33.2
(n = 3/3)
ND
Mean Ct obtained by qPCR for IP route and aerosol routes in mice, IP and IV routes in rats. In each case, the first line is the result: positive / negative, the second line is the mean Ct
obtained for the positive samples tested, the third line is the number of positive samples/number of tested samples. ND, Not Done.
peritoneum to the bloodstream as well as from the bloodstream
into several deep organs. The NALT, a rodent equivalent of the
human tonsils, appeared to be an important target organ after
aerosol transmission, as attested by its early and lasting carriage
at high viral loads as compared to other organs. The viral load, as
assessed by quantification of DNA copies when possible, did not
increase over the time regardless the animal model or the route
of inoculation, so we cannot clearly conclude to the evidence of
in vivo replication of the virus.
The presence of giant viruses in mammalian hosts was
first suggested for mimiviruses, other giant viruses which are
close relatives of marseilleviruses. Thus, Mimivirus-associated
pneumonia have been described, notably in one patient from
which the virus could be isolated from its broncho-alveolar
fluid (Saadi et al., 2013a). Another case featuring a laboratory
technician handling Mimivirus who developed unexplained
pneumonia and seroconversion to Mimivirus antigens which has
also been reported (Raoult et al., 2006; Saadi et al., 2013a,b).
Moreover, the sero-epidemiological data show a significantly
higher seroprevalence for mimivirus in pneumonia patients than
in controls. Indeed, on 887 serum samples including 376 from
patients with community-acquired pneumonia, and 511 from
healthy control subjects, 9.66% of the first group exhibited a
positive titer of antibodies to Mimivirus whereas only 2.3% of the
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TABLE 2 | Summary of results obtained by amoebal co culture of blood and organs of rats and mice inoculated with Marseillevirus.
Coculture Day 0 Day 1 Day 2 Day 3 Day 7 Day 14 Day 21 Day 30 Day 43
IP route Rats Blood Positive
(n = 1/2)
Positive
(n = 1/4)
ND Negative
(n = 0/2)
Negative
(n = 0/4)
Negative
(n = 0/3)
ND ND Negative
(n = 0/1)
Spleen ND Positive
(n = 2/2)
ND Positive
(n = 1/2)
Positive
(n = 3/4)
Positive
(n = 3/3)
ND ND Negative
(n = 0/1)
Liver ND Positive
(n = 2/2)
ND Negative
(n = 0/2)
Positive
(n = 1/4)
Negative
(n = 0/3)
ND ND Negative
(n = 0/1)
Mice Blood Positive
(n = 3/4)
Positive
(n = 1/4)
Negative
(n = 0/3)
ND Negative
(n = 0/3)
ND Negative
(n = 0/1)
ND ND
Spleen Positive
(n = 4/4)
Positive
(n = 4/4)
Positive
(n = 2/3)
ND Positive
(n = 2/3)
ND Negative
(n = 0/1)
ND ND
Liver ND ND ND ND ND ND ND ND ND
IV route Rats Blood ND Positive
(n = 4/4)
Positive
(n = 2/2)
Negative
(n = 0/3)
Negative
(n = 0/3)
Negative
(n = 0/3)
Negative
(n = 0/3)
Negative
(n = 0/3)
Negative
(n = 0/2)
Spleen ND Positive
(n = 4/4)
ND Positive
(n = 2/3)
Positive
(n = 2/3)
Positive
(n = 3/3)
Positive
(n = 2/2)
Negative
(n = 0/3)
Negative
(n = 0/2)
Liver ND Positive
(n = 4/4)
ND Positive
(n = 3/3)
Positive
(n = 2/3)
Positive
(n = 2/3)
Negative
(n = 0/2)
Negative
(n = 0/3)
Negative
(n = 0/2)
Aerosol
route
Mice Blood Negative
(n = 0/4)
Negative
(n = 0/5)
ND ND Negative
(n = 0/18)
Negative
(n = 0/15)
Negative
(n = 0/14)
Negative
(n = 0/5)
ND
Spleen Negative
(n = 0/4)
Negative
(n = 0/5)
ND ND Negative
(n = 0/18)
Negative
(n = 0/15)
Negative
(n = 0/14)
Negative
(n = 0/5)
ND
Liver Negative
(n = 0/4)
Negative
(n = 0/5)
ND ND Negative
(n = 0/18)
Negative
(n = 0/15)
Negative
(n = 0/14)
Negative
(n = 0/5)
ND
Lung Positive
(n = 4/4)
Positive
(n = 15/15)
ND ND Positive
(n= 16/18)
Positive
(n = 8/15)
Positive
(n = 1/14)
Positive
(n = 1/4)
ND
NALT Positive
(n = 2/2)
Positive
(n = 11/11)
ND ND Positive
(n= 18/18)
Positive
(n = 14/15)
Positive
(n = 11/14)
Positive
(n = 3/3)
ND
For some times of evaluation, the number of samples tested by coculture is different from those appearing in the table showing PCR results because of either insufficient quantity or
ininterpretable results of PCR (negativity for internal control DNA and Marseillevirus DNA). In each case, the second line is the number of positive samples / number of tested samples.
ND = Not done.
FIGURE 2 | Overall detection and persistence of Marseillevirus DNA by PCR
after an intraveinous inoculation in rats, during the 43 day long experiment.
healthy controls were positive (p = 0.01; La Scola et al., 2005).
Moreover, Mimivirus DNA was detected by PCR in respiratory
samples from a patient with hospital-acquired pneumonia (La
Scola et al., 2005). However, studies using PCR assays were more
difficult to conduct because of the great genetic variability of
the mimiviruses genomes, a feature shared with marseilleviruses.
Thus, Dare et al. screened 496 respiratory specimens from
nine pneumonia patient populations for Mimivirus by qPCR,
performed mainly on nasal and nasopharyngeal swabs. All the
samples tested were negative (Dare et al., 2008).
The clinical data mentioned above were completed by a
mouse model reproducing histologically proven pneumonia at
days 3 and 7 PI in C57BL/6 and BALB/c mice respectively
(Khan et al., 2007). Another giant virus, Acanthocystis turfacea
Chlorella Virus 1, a close relative of amoeba giant viruses from the
family Phycodnaviridae, was found in oro-pharyngeal samples
from patients and was associated with a decrease in cognitive
functioning (Yolken et al., 2014). A mouse model showed that
digestive inoculation of the virus induced, modifications in the
brain of the expression of genes involved in cognitive functions.
These authors supposed that the virus was responsible for
cognitive impairment, although such a hypothesis would need
further investigation (Yolken et al., 2014).
In the present work, the IP model showed an early transient
blood dissemination of the virus both in mice and rats, and its
persistence in the spleen for at least 2 weeks. The IV model
also showed that after a transient passage in the bloodstream,
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FIGURE 3 | Positive (A) NALT and (B) lung samples, according to the technique (PCR or amoebal co-culture), after pulmonary inoculation. The percentage of positive
samples is indicated on the y axis. The absolute numbers of positive samples are indicated by labels on the plots.
FIGURE 4 | Positive (A) liver and (B) spleen samples, according to the technique (PCR or amoebal co-culture), after intravenous inoculation in rats. The percentage of
positive samples is indicated on the y axis. The absolute numbers of positive samples are indicated by labels on the plots.
viable Marseillevirus was detected as much as 3 weeks later in
the spleen. In the aerosolized model, the virus was detected at
a higher frequency in NALT than in lung samples, especially
at later time points. Interestingly, the DNA viral load at day
30 PI was 4.7 log units of viral copies per million of murine
cells, in other words, not that different to the load just after
aerosolization (5.9 log units of viral copies per million of murine
cells). Conversely, in the lungs, the viral load regularly decreased
until it was undetectable at day 30 PI. Although our results do
not show a viral replication, the long persistence into the NALT
of aerosol inoculated mice is congruent with the human case of
Marseillevirus persistence in pharyngeal samples (Aherfi et al.,
2016b).
The use of two techniques (amoebal co-culture and PCR) for
detecting the virus, complemented with antibody detection
assays under strict control conditions and predefined
strict criteria for the PCR and serology interpretations
strengthens our results. In addition, double blind reading
of immunofluorescence assays was performed. This could have
led to the under diagnosis of positive serological responses
after aerosolization. Concerning the antibody response
after parenteral inoculations, a strong concordance was
obtained.
The absence of any pathological findings in the organs,
including the lungs, could be due to an absence of a detectable
host cellular immune response or to the invasiveness of the
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FIGURE 5 | Standardized viral loads (viral copies per million murine cells) in the lungs and the NALT of aerosol-inoculated mice by Marseillevirus suspension.
Diamonds represent the viral loads in the NALT and circles represent the viral loads in the lungs for each animal. The mean viral loads are represented for each time
point by thick dashes. The viral loads in lungs and NALT, and at different time points were compared by using Wilcoxon-Mann Whitney test, using sigmaplot 13
SYSTAT software Inc. software. Single asterisks show the time points with significant differences between NALT and lung viral loads. Double asterisks show significant
differences between the NALT viral loads at different time points.
pathogen. However, it is not knownwhether immune-suppressed
animals or repetitive contact may have induced some of these
cases.
The presence of marseilleviruses in humans has previously
been reported from different cases, including blood from healthy
donors, one case of adenitis, one case of Hodgkin’s lymphoma
and, as a chronic carriage, in a patient with neurological
symptoms (Popgeorgiev et al., 2013a,c; Aherfi et al., 2016a,b).
Our results in mice and rats reinforce the hypothesis of chronic
carriage. Considering the low number of proportion of positive
clinical samples, either for mimiviruses or for marseilleviruses,
we can hypothesize that the techniques used to detect giant
viruses lack of sensitivity. There are undeniably, a lot of technique
improvements that remain to do, both on culture isolation
and PCR techniques for detecting giant viruses in clinical
samples. Thus, the low number of viral particles combined
with the lack of sensitivity of the techniques used may lead
to a low number of positive samples in the samples collected.
It is noteworthy that it has not been established to date that
marseilleviruses can replicate in mammals, or cause a disease.
However, giant viruses of amoebae, which are very distant
from other viruses both by their phenotypic and genotypic
features, might act on mammal cells by a different mechanism
than replication. Thus, the big size of giant viruses may
probably enable their ingestion by phagocytic cells, without
the intervention of a specific cell receptor (Ghigo et al.,
2008).
The absence of pathological findings in the tested organs
points toward the healthy carriage of the virus by the host.
However, further investigations should be performed to assess
whether recurrent contact withMarseillevirus or if an inoculation
in immunocompromised mice may favor a pathologic outcome.
Although the virus was not detected in the lymph nodes in our
work, it was found to be viable for as long as 2–3 weeks in the
spleen after IP and IV inoculation, respectively.
Given the high prevalence of marseilleviruses in the
environment, and the possibility of a long term carriage, further
investigations are needed on the mechanisms used by these
viruses to escape rapid destruction by immune system. It
would be interesting to try culturing Marseillevirus on different
professional phagocytic cells, as was performed for Mimivirus,
to assess if at least some of them are permissive. To date,
only amoebas are known to be a host for Marseillevirus that
allow a complete lytic replication cycle. However, if humans
are possible carriers of Marseillevirus, they might serve as
vectors for their dissemination in the environment. In summary,
this experimental model is a first step toward the assessment
of Marseillevirus infection in a mammalian host. Its long
persistence, especially in the NALT, merits further study to
assess the possibility of a longer viral persistence and reinforces
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the pertinence of systematic Marseillevirus detection in subjects
presenting with unexplained upper airway/pharyngeal or adenitis
clinical pictures.
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